Stewart Hen, Director at ALLOS THERAPEUTICS INC (ALTH), bought 3,500,000 shares at $5.64 ($19.7M) on 2008-05-29, disclosed to the SEC on 2008-05-30.
Open-market purchase of $19.7M ALTH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.